Eur Rev Med Pharmacol Sci 2021; 25 (7): 2822-2822

DOI: 10.26355/eurrev_202104_25517

BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients

L. Wang, Q. Chunyan, Y. Zhou, Q. He, Y. Ma, Y. Ga, X. Wang

Department of Pharmacy, People’s Hospital of Yuxi City, Yuxi, Yunnan Province, China.


The article “BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients, by L. Wang, Q. Chunyan, Y. Zhou, Q. He, Y. Ma, Y. Ga, X. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (18): 4064-4070–PMID: 29028095” has been withdrawn from the authors due to incorrect data in the conclusions. The authors are performing further experiments and they found some novelties. Therefore, they hope to re-write and conceive the paper to better clarify their findings.

The Publisher apologizes for any inconvenience this may cause.

BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients

Free PDF Download

To cite this article

L. Wang, Q. Chunyan, Y. Zhou, Q. He, Y. Ma, Y. Ga, X. Wang
BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 7
Pages: 2822-2822
DOI: 10.26355/eurrev_202104_25517